Biogen (BIIB) Selling, General & Administrative (2009 - 2026)
Biogen's Selling, General & Administrative came in at $709.7 million for Q2 2026, up 21.6% from $583.8 million a year earlier and up 16.9% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Selling, General & Administrative (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biogen reported Selling, General & Administrative of $2.59 billion, up 7.0% year-over-year; for FY2025, it was $2.43 billion, up 1.2% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of -0.6% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $2.4 billion in FY2024 (-5.7%), $2.55 billion in FY2023 (+6.1%), $2.4 billion in FY2022 (-10.1%) and $2.67 billion in FY2021 (+6.8%).
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative since Q3 2023.
- Year-over-year, Selling, General & Administrative has increased for five consecutive quarters, with growth averaging 2.4% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2023 (growth of 39.9%), and the weakest in Q3 2024 (a decline of 25.3%).
- Business Quant data shows BIIB's Selling, General & Administrative at $607.3 million (Q1 2026), $682.5 million (Q4 2025) and $594.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,117.95 Bn | 1,086.53 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 610.55 Bn | 529.08 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 500.38 Bn | 473.49 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 359.80 Bn | 314.18 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 291.32 Bn | 255.31 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 258.14 Bn | 231.82 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 234.48 Bn | 189.88 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 195.69 Bn | 169.88 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 167.75 Bn | 114.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Biogen | 34.76 Bn | 21.42 Bn | 1.96 Bn | 709.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 709.70 Mn |
| Mar 31, 2026 | 607.30 Mn |
| Dec 31, 2025 | 682.50 Mn |
| Sep 30, 2025 | 594.80 Mn |
| Jun 30, 2025 | 583.80 Mn |
| Mar 31, 2025 | 572.50 Mn |
| Dec 31, 2024 | 680.00 Mn |
| Sep 30, 2024 | 588.40 Mn |
| Jun 30, 2024 | 553.80 Mn |
| Mar 31, 2024 | 581.50 Mn |
| Dec 31, 2023 | 608.50 Mn |
| Sep 30, 2023 | 788.20 Mn |
| Jun 30, 2023 | 548.00 Mn |
| Mar 31, 2023 | 605.00 Mn |
| Dec 31, 2022 | 632.80 Mn |
| Sep 30, 2022 | 563.30 Mn |
| Jun 30, 2022 | 572.60 Mn |
| Mar 31, 2022 | 634.90 Mn |
| Dec 31, 2021 | 787.90 Mn |
| Sep 30, 2021 | 654.10 Mn |
API Access
Biogen Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();